pRECIST: Guidelines for Response Criteria for Use in Trials Testing Therapeutics in Pancreatic Cancer. Martin RCG 2nd, Scheon E, Govindarajan N, Verdeur M, et al. Pancreas 2026 Apr 3. doi: 10.1097/MPA.0000000000002640.

Read + Share

Amedeo Smart

Independent Medical Education

Martin RCG 2nd, Scheon E, Govindarajan N, Verdeur M, et al. pRECIST: Guidelines for Response Criteria for Use in Trials Testing Therapeutics in Pancreatic Cancer. Pancreas 2026 Apr 3. doi: 10.1097/MPA.0000000000002640.
PMID: 41941588